VANCOUVER, British Columbia, Oct. 08, 2019 — BOUGAINVILLE VENTURES INC. (CSE: BOG) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Bougainville” or the “Company”) is pleased to announce that further to the signing of the definitive agreement to complete the acquisition of Thrive Nutrition Products Ltd. (“Thrive Wellness”) announced in the Company news release dated September 24, 2019, the Company has appointed Mr. Andy Dhaliwal, President of Thrive Wellness to Vice President of Sales and Distribution for Bougainville Ventures Inc. Thrive Wellness is a preeminent distributor of hemp & cannabinoid-focused natural health products under the “THRIVE WELLNESS” brand.
About Thrive Nutrition Products Ltd.
Thrive Wellness is a distributor of premium hemp and natural health products with operations currently in Canada and the USA. Thrive specializes in the development, marketing and distribution of cannabinoid products refined into their own natural health product brand. The company was founded in Vancouver, British Columbia and is the first of its kind with national retail distribution in Canada. Thrive has achieved $2,500,000 CDN in sales through retail distribution, its’ e-commerce website and their relationship with Nutrition House, Canada’s leading Natural Health Product franchise. Founded in 1979 the company began franchising in 1993 and now operates over 45 retail stores, located in high profile shopping centers across Canada, and in the USA. www.nutritionhouse.com
CEO, Andy Dhaliwal Comments:
“I am very excited to be a joining a team that is extremely well positioned for significant growth in the emerging cannabis & hemp markets. I look forward to helping Bougainville continue building shareholder value and to increase our international exposure through this partnership. I am particularly keen on the CBD opportunity in the U.S., where Bougainville already has resources available.”
Mr. Dhaliwal is a pioneering expert in the marketing of cannabis, hemp, and natural health products, and brings over 12 years of experience in the industry. In addition to serving as the CEO of Thrive Wellness, he was an advisor for the Province of British Columbia’s Cannabis Operations, where he advised on corporate development and sales optimization.
To learn more about what this news means to the shareholders visit https://marketnewsfirst.com/bog-news, as well as on the company’s site.
About the CBD Market
Bank of America projects a spend of $1.3 Billion on CBD in Canada by 2022, while $1.9 Billion is being spent in the USA currently, and another $4.4 Billion in Europe this year. Demand for CBD and Hemp is increasing year over year, with Merrill Lynch predicting an $11.5 Billion American market by 2032.
About Bougainville Ventures, Inc.
Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington State, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.
On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.
Andy Jagpal, President and Director
For further information, please contact Zoltan, IR Representative at: 604-722-0305 email@example.com. Or toll free at 1-877-517-7816
http://bougainvilleinc.com/ https://twitter.com/bougainvilleinc www.thriveCBD.org
FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.